|
MITIGLINIDE CALCIUM | ||
PRODUCT IDENTIFICATION |
||
CAS NO. | 145375-43-5
(Base) 145525-41-3 (Calcium) |
|
EINECS NO. | ||
FORMULA | C38H48CaN2O6 | |
MOL WT. | 668.88 | |
H.S. CODE |
||
TOXICITY |
||
SYNONYMS | Glufast; Calcium 2-Benzyl-3-(hexahydro-2-isoindolinylcarbonyl)propionate; | |
(-)-(2S,3a,7a-cis)-alpha-Benzylhexahydro-gamma-oxo-2-isoindolinebutyric acid dicalcium salt dihydrate; Calcium 2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl)propionate dihydrate; Calcium (2S)-4-((3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)-2-benzyl-4-oxo-butanoate; | ||
SMILES |
|
|
CLASSIFICATION |
HYPOGLYCEMIC AGENTS / | |
PHYSICAL AND CHEMICAL PROPERTIES |
||
PHYSICAL STATE | white to off-white crystalline powder | |
MELTING POINT | 146 - 148 C | |
BOILING POINT | ||
SPECIFIC GRAVITY | ||
SOLUBILITY IN WATER | ||
pH | ||
VAPOR DENSITY |
| |
AUTOIGNITION |
| |
NFPA RATINGS |
||
REFRACTIVE INDEX |
||
FLASH POINT |
| |
STABILITY | Stable under ordinary conditions. | |
GENERAL DESCRIPTION & APPLICATIONS |
||
Antidiabetics include:
Mitiglinide is a drug belongs to a family of meglitinide to treat diabetes type 2 by blocking the potassium channels in beta cells. It is a rapid and short-acting hypoglycemic agent which stimulate the pancreas to produce more insulin by closing the ATP-sensitive K(+) (K(ATP)) channels in pancreatic beta-cells. |
||
SALES SPECIFICATION (USP24) | ||
APPEARANCE |
white to off-white crystalline powder | |
ASSAY (HPLC) |
99.0% min | |
MELTING POINT |
145- 145 C |
|
TRANSPORTATION | ||
PACKING |
| |
HAZARD CLASS | ||
UN NO. | ||
OTHER INFORMATION | ||
Hazard Symbols: , Risk Phrases: , Safety Phrases: 22-24/25 |
|
|